Biostar Pharmaceuticals Stock Market Value
| BSPM Stock | USD 0.0001 0.00 0.00% |
| Symbol | Biostar |
Biostar Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biostar Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biostar Pharmaceuticals.
| 12/12/2025 |
| 01/11/2026 |
If you would invest 0.00 in Biostar Pharmaceuticals on December 12, 2025 and sell it all today you would earn a total of 0.00 from holding Biostar Pharmaceuticals or generate 0.0% return on investment in Biostar Pharmaceuticals over 30 days. Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter and prescription pharmaceutical produ... More
Biostar Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biostar Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biostar Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Biostar Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biostar Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biostar Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Biostar Pharmaceuticals historical prices to predict the future Biostar Pharmaceuticals' volatility.Biostar Pharmaceuticals Backtested Returns
We have found three technical indicators for Biostar Pharmaceuticals, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biostar Pharmaceuticals are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Biostar Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Biostar Pharmaceuticals time series from 12th of December 2025 to 27th of December 2025 and 27th of December 2025 to 11th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biostar Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Biostar Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biostar Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Biostar Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biostar Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Biostar Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Biostar Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biostar Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biostar Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biostar Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biostar Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Biostar Pharmaceuticals Lagged Returns
When evaluating Biostar Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biostar Pharmaceuticals pink sheet have on its future price. Biostar Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biostar Pharmaceuticals autocorrelation shows the relationship between Biostar Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Biostar Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Biostar Pink Sheet
Biostar Pharmaceuticals financial ratios help investors to determine whether Biostar Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostar with respect to the benefits of owning Biostar Pharmaceuticals security.